Last updated: 11/04/2018 10:36:32
Clinical Study Of Migraine Evolution
GSK study ID
S2W106188
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A multicenter study to determine the clinical characteristics of the temporal aspects of migraine in a Canadian population: Clinical Study Of Migraine Evolution (C-SOME)
Trial description: Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
250
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Prospective Study
Clinical publications:
Not applicable
Medical condition
Migraine Headache
Product
Not applicable
Collaborators
None
Study date(s)
January 2006 to May 2006
Type
Observational
Phase
4
Participation criteria
Sex
Female & Male
Age
18+ years
Accepts healthy volunteers
No
- Subject is outpatient.
- Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
- Subject has other chronic pain condition(s) not associated with migraine
- Subject is unable to understand the schedule/questionnaire.
Inclusion and exclusion criteria
Inclusion criteria:
- Subject is outpatient.
- Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
- Subject is able to comprehend the study procedures and to comply with study requirements.
Exclusion criteria:
- Subject has other chronic pain condition(s) not associated with migraine
- Subject is unable to understand the schedule/questionnaire.
Trial location(s)
Location
GSK Clinical Trials Call Centre
Saint John, NB, Canada, E2L 4L2
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Montreal, QC, Canada, H3A 2B4
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Calgary, AB, Canada, T2N 2T9
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Longueuil, QC, Canada, J4L 4N5
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Hamilton, ON, Canada, L8N 1Y2
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Toronto, ON, Canada, M5S 1B6
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Richmond, BC, Canada, V6X 1A3
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Halifax, NS, Canada, B3H 3A7
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Vancouver, BC, Canada, V5Z 1M9
Status
Recruitment Complete
Location
GSK Clinical Trials Call Centre
Unionville, ON, Canada, L3R 0W7
Status
Recruitment Complete
Study documents
No study documents available.
Results overview
No study documents available
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2006-01-05
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website